What type of study is this?

This is a Systematic Review study (also classified as: Case-Control Study).

September 26, 2025Inflammatory Bowel DiseasesOpen Access

Gut Mycobiome in Inflammatory Bowel Disease: A Systematic Review of Case-Control Studies

View Full Paper

Ask AI

Bookmark

Differences in beta diversity were consistently found between IBD patients and controls, indicating a notable alteration in the mycobiome.
Among 27 studies involving 1406 IBD patients, an increase in Candida was observed in both Crohn's disease and ulcerative colitis.
This systematic review assessed variations across geographical locations, highlighting the heterogeneous nature of study populations and methodologies.
Future research should focus on standardization in sample collection and analysis to enable better validation of findings related to the mycobiome.

No takes yet. Share an insight, caveat, or question.

Systematic review identifies mycobiome changes in inflammatory bowel disease, suggesting standardization may improve research outcomes.

Füchtbauer et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark